Pseudomonas aeruginosa outer membrane protein PA0427

Details Pseudomonas aeruginosa outer membrane protein PA0427 Pseudomonas aeruginosa outer membrane protein PA0427

2007-03-30

2011-12-27

Graser, Jennifer (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S234100, C424S270100, C530S387100, C530S388100

Reexamination Certificate

active

08084044

ABSTRACT:
An object of the present invention is to provide a protein or peptide antigen and an antibody against it, for use in the diagnosis, prevention, or treatment of diseases associated withPseudomonas aeruginosa. According to the present invention, there is provided a protein or peptide derived fromPseudomonas aeruginosaouter membrane protein PA0427 and an antibody against it, for use in the diagnosis, prevention, or treatment of diseases associated withPseudomonas aeruginosa.

REFERENCES:
patent: 6551795 (2003-04-01), Rubenfield et al.
patent: 2007/049770 (2007-05-01), None
Mikayama et al. (Nov. 1993. Proc.Natl.Acad.Sci. USA, vol. 90 : 10056-10060).
Rudinger et al. (Jun. 1976. Peptide Hormones. Biol.Council. pp. 5-7).
Greenspan et al (Nature Biotechnology 7: 936-937, 1999).
Chothia et al (The EMBO Journal, 1986, 5/4:823-26).
Q. Zhao et al., “Contribution of Outer Membrane Efflux Protein OprM to Antibiotic Resistance inPseudomonas aeruginosaIndependent of MexAB”, Antimicrobial Agents and Chemotherapy, Jul. 1998, vol. 42, No. 7, pp. 1682-1688.
N. Gotoh et al., “Characterization of the MexC-MexD-OprJ Multidrug Efflux System inΔmexA-mexB-oprMMutants ofPseudomonas aeruginosa”, Antimicrobial Agents and Chemotherapy, Aug. 1998, vol. 42, No. 8, pp. 1938-1943.
A. Nakajima et al., “Localization of the Outer Membrane Subunit OprM of Resistance-Nodulation-Cell Division Family Multicomponent Efflux Pump inPseudomonas aeruginosa”, The Journal of Biological Chemistry, vol. 275, No. 39, pp. 30064-30068, Sep. 29, 2000.
I. Ziha-Zarifi et al., “In Vivo Emergence of Multidrug-Resistant Mutants ofPseudomonas aeruginosaOverexpressing the Active Efflux System MexA-MexB-OprM”, Antimicrobial Agents and Chemotherapy, vol. 43, No. 2, pp. 287-291, Feb. 1999.
T. Nakae, “Yakuzai Haishutsu Pump Hatsugen ni yoru Tazai Taiseikabu no Jinsoku Kenshutsuho no Kaihatsu”, Heisei 11 Nendo Kosei Kagaku Kenkyuhi Hojokin Saikin no Yakuzai Taisei Kiko no Bunshi Kaiseki to Taisei Kijobetsu Jinsoku Kenshutsuho no Kanrusu Kenkyu Kenkyu Hokokusho Heisei 12 Nen 4 Gatsu, pp. 79-82, Apr. 2000.
U. Baumann et al., “Recombinant OprF-Oprl as a Vaccine AgainstPseudomonas aeruginosaInfections”, Vaccine, vol. 22, No. 7, pp. 840-847, 2004.
H. E. Gilleland et al., “Use of Synthetic Peptides to Identify Surface-Exposed, Linear B-Cell Epitopes Within Outer Membrane Protein F ofPseudomonas aeruginosa”, Current Microbiology, vol. 31, No. 5, pp. 279-286, 1995.

Affiliated with

Also associated with

Rating

Pseudomonas aeruginosa outer membrane protein PA0427 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pseudomonas aeruginosa outer membrane protein PA0427, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pseudomonas aeruginosa outer membrane protein PA0427 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4296480